Dermatophytosis (Ringworm)
What is Dermatophytosis (ringworm)?
Dermatophytosis, commonly called ringworm, is a superficial fungal infection of the skin, hair, or nails caused by a group of fungi known as dermatophytes. Despite its name, the condition is not caused by a worm; the name derives from the characteristic round, âringâshapedâ lesions that often appear on the skin.
Dermatophytes feed on keratin, the protein that makes up the outermost layers of skin, hair shafts, and nails. When the fungi colonize these structures, they cause itching, scaling, and the classic redâbordered, clearâcenter patches.
Most cases are mild and respond well to topical therapy, but certain populationsâchildren, athletes, immunocompromised persons, and people with diabetesâmay develop more extensive disease that requires systemic treatment.
Common Causes
Dermatophytosis is not a single disease; it results from infection with any of several species of dermatophyte fungi. Below are the most frequent causes and the settings in which they are acquired.
- Trichophyton rubrum â the most common cause of athleteâs foot and nail (onychomycosis) infections.
- Trichophyton mentagrophytes â often contracted from animals (especially rodents) and from soil.
- Microsporum canis â a zoonotic fungus spread by cats and dogs; the leading cause of tinea capitis in children.
- Epidermophyton floccosum â primarily causes tinea corporis (body) and tinea cruris (groin) and spreads via direct skinâtoâskin contact.
- Trichophyton tonsurans â a common cause of scalp ringworm (tinea capitis) in North America.
- Microsporum gypseum â a soilâborne fungus that can affect people who work outdoors.
- Trichophyton verrucosum â transmitted from cattle; usually seen in farm workers.
- Anthropophilic infections â fungi that prefer human hosts and spread in crowded settings such as schools, locker rooms, and gyms.
- Zoonotic infections â acquired from pet or livestock contact (e.g., cats, dogs, pigs, goats).
- Contact with contaminated surfaces â towels, clothing, bedding, or athletic equipment that have not been properly cleaned.
Associated Symptoms
The clinical picture varies with the site of infection, but the following features are typical.
- Itchy, red, circular rash with a raised, scaly border and a clearer center.
- Scaling or flaking of the skin, especially at the edges of the lesion.
- Hair loss in scalp infections (tinea capitis), sometimes leaving black or gray âbrokenâoffâ hairs.
- Thickened, discolored nails (onychomycosis) that become brittle or crumbly.
- Blisters or pustules may develop around the rash in severe cases.
- Foul odor is occasionally reported when feet or groin are involved.
- Secondary bacterial infection indicated by increased pain, swelling, warmth, or pus.
When to See a Doctor
Most ringworm infections can be selfâlimited, yet medical evaluation is warranted when any of the following occur:
- Lesions do not improve after 2 weeks of overâtheâcounter antifungal cream.
- Rapid spreading of the rash, especially across large body areas.
- Signs of bacterial infection (redness spreading, warmth, pus, fever).
- Scalp involvement in children (tinea capitis) â may lead to permanent hair loss without treatment.
- Onychomycosis (nail infection) that is painful, spreading, or causing functional problems.
- Immunocompromised status (e.g., HIV, chemotherapy, organ transplant) â infections can become invasive.
- Diabetes or peripheral vascular disease â higher risk of complications.
Diagnosis
Clinical Examination
Healthcare providers first perform a visual inspection. The classic âringâ shape, along with the distribution of lesions, often points to dermatophytosis.
Laboratory Tests
- Woodâs lamp examination â certain species (e.g., Microsporum canis) fluoresce under ultraviolet light.
- Potassium hydroxide (KOH) preparation â a skin scraping is placed on a slide with KOH; under a microscope, hyphae (fungal threads) become visible.
- Fungal culture â samples are placed on special media; growth may take 1â4 weeks but identifies the exact species.
- Fungal PCR â a rapid molecular test increasingly used in specialized labs.
- Nail clipping for histology â when onychomycosis is suspected, nail fragments are examined.
When Biopsy Is Needed
Rarely, a skin biopsy is performed if the rash does not respond to therapy or if other dermatoses (e.g., psoriasis, eczema, cutaneous malignancy) are in the differential diagnosis.
Treatment Options
Topical Antifungals
Firstâline therapy for limited skin disease (tinea corporis, cruris, pedis, and limited nail involvement) includes:
- Terbinafine 1% cream â applied twice daily for 2â4 weeks.
- Clotrimazole 1% cream or lotion â 2â3 times daily for 4 weeks.
- Econazole, miconazole, or ketoconazole â similar regimens.
- Ciclopirox 8% lacquer â for mild nail infection; daily application for 48 weeks.
Oral Antifungals
Systemic therapy is required for extensive skin disease, scalp involvement, or nail infection.
- Terbinafine â 250âŻmg once daily for 2â6 weeks (skin) or 12 weeks (nails).
- Itraconazole â pulse therapy 200âŻmg twice daily for 1 week per month, repeated 2â4 months for nails.
- Fluconazole â 150âŻmg weekly for 6â12 weeks (nail) or daily for 2â4 weeks (skin).
- Griseofulvin â older agent; 500â1000âŻmg daily for 6â8 weeks (skin) or up to 12 weeks (scalp).
Because oral agents can interact with other medications and affect liver function, clinicians usually order baseline liverâfunction tests and monitor during therapy.
Adjunctive Home Care
- Keep the affected area clean and dry; moisture promotes fungal growth.
- Wash hands thoroughly after applying medication.
- Use a separate towel for the infected area and launder it in hot water (â„60âŻÂ°C) weekly.
- Apply antifungal powder to feet or groin to reduce humidity.
- Avoid tight, nonâbreathable clothing; opt for cotton or moistureâwicking fabrics.
- For scalp infections, use a medicated shampoo (e.g., ketoconazole 2%) 2â3 times weekly for at least 4 weeks.
Special Populations
Children with tinea capitis often require oral therapy (usually terbinafine or griseofulvin) because topical agents cannot penetrate the hair shaft. Pregnant or lactating women should discuss risks; topical agents are generally safe, while oral terbinafine is contraindicated.
Prevention Tips
Because dermatophytosis spreads by direct contact or contaminated objects, simple hygiene measures dramatically lower risk.
- Dry skin thoroughly after bathing, especially between toes and in skin folds.
- Wear flipâflops or shower shoes in public locker rooms, pools, and communal showers.
- Do not share personal items: towels, combs, hairbrushes, socks, or shoes.
- Wash clothing, bedding, and towels in hot water (â„60âŻÂ°C) and dry on high heat.
- For pets, schedule regular veterinary checkâups; treat any suspected ringworm in animals promptly.
- Use a fungicidal spray on gym equipment, mats, and yoga mats if they are shared.
- Trim nails short; keep feet and hands wellâmoisturized but not overly wet.
- Educate children about not picking at scaly lesions and the importance of handâwashing.
Emergency Warning Signs
- Rapidly spreading redness with swelling, warmth, or severe pain â possible bacterial cellulitis.
- Fever >38âŻÂ°C (100.4âŻÂ°F) accompanying the rash.
- Pus, drainage, or an ulcerating lesion.
- Signs of a severe allergic reaction (hives, difficulty breathing, swelling of the face or throat) after applying a topical medication.
- Sudden loss of sensation, significant skin necrosis, or deep tissue involvement in immunocompromised patients.
If any of these occur, go to the nearest emergency department or call your local emergency number.
References
Information in this article is based on current clinical guidelines and reputable sources, including:
- Mayo Clinic. âRingworm (tinea)â. mayoclinic.org
- Centers for Disease Control and Prevention (CDC). âDermatophytosis (Ringworm)â. cdc.gov
- National Institutes of Health (NIH) â MedlinePlus. âRingwormâ. medlineplus.gov
- World Health Organization (WHO). âFungal infectionsâ. who.int
- Cleveland Clinic. âRingworm (Tinea)â. clevelandclinic.org
- Journal of the American Academy of Dermatology. âManagement of Dermatophyte Infectionsâ. 2023; 89(4): 673â682.